| アブストラクト | Background: Although reductions in hospitalizations for myocardial infarction and heart failure have been reported during the period of COVID-19 pandemic restrictions, it is unclear how the overall number of hospitalizations for cardiovascular disease (CVD) treatment changed in the early stages of the pandemic. Methods and Results: We analyzed the records of 574 certified hospitals affiliated with the Japanese Circulation Society and retrieved data from April 2015 to March 2020. Records were obtained from the nationwide Japanese Registry of All Cardiac and Vascular Diseases-Diagnosis Procedure Combination database. A quasi-Poisson regression model was used to estimate the number of hospitalizations for CVD treatment. Between January and March 2020, when the number of COVID-19 cases was relatively low in Japan, the actual/estimated number of hospitalizations for acute CVD was 18,233/21,634 (84.3%), whereas the actual/estimated number of scheduled hospitalizations was 16,921/19,066 (88.7%). The number of hospitalizations for acute heart failure and scheduled hospitalizations for valvular disease and aortic aneurysm were 81.1%, 84.6%, and 83.8% of the estimated values, respectively. A subanalysis that considered only facilities without hospitalization restrictions did not alter the results for these diseases. Conclusions: The spread of COVID-19 was associated with a decreased number of hospitalizations for CVD in Japan, even in the early stages of the pandemic. |
|---|
| ジャーナル名 | Circulation reports |
|---|
| Pubmed追加日 | 2022/8/30 |
|---|
| 投稿者 | Sugimoto, Tadafumi; Mizuno, Atsushi; Yoneoka, Daisuke; Matsumoto, Shingo; Matsumoto, Chisa; Matsue, Yuya; Ishida, Mari; Nakai, Michikazu; Iwanaga, Yoshitaka; Miyamoto, Yoshihiro; Node, Koichi |
|---|
| 組織名 | Department of Cardiology and Nephrology, Mie University Graduate School of;Medicine Tsu Japan.;Information and Communication Committee, the Japanese Circulation Society Tokyo;Japan.;Department of Cardiovascular Medicine, St. Luke's International Hospital Tokyo;Penn Medicine Nudge Unit, University of Pennsylvania Philadelphia, PA USA.;Leonard Davis Institute for Health Economics, University of Pennsylvania;Philadelphia, PA USA.;Infectious Disease Surveillance Center, National Institute of Infectious Diseases;Tokyo Japan.;Division of Cardiovascular Medicine, Department of Internal Medicine, Toho;University Faculty of Medicine Tokyo Japan.;Department of Cardiology, Center for Health Surveillance and Preventive Medicine,;Tokyo Medical University Tokyo Japan.;Department of Cardiovascular Biology and Medicine, Juntendo University Graduate;School of Medicine Tokyo Japan.;Department of Cardiovascular Physiology and Medicine, Graduate School of;Biomedical and Health Sciences, Hiroshima University Hiroshima Japan.;Department of Medical and Health Information Management, National Cerebral and;Cardiovascular Center Suita Japan.;Open Innovation Center, National Cerebral and Cardiovascular Center Suita Japan.;Department of Cardiovascular Medicine, Saga University Saga Japan. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/36032385/ |
|---|
